| Title : Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia - Zugno_2013_Metab.Brain.Dis_28_501 |
| Author(s) : Zugno AI , Juliao RF , Budni J , Volpato AM , Fraga DB , Pacheco FD , Deroza PF , Luca RD , de Oliveira MB , Heylmann AS , Quevedo J |
| Ref : Metabolic Brain Disease , 28 :501 , 2013 |
| Abstract : Zugno_2013_Metab.Brain.Dis_28_501 |
| ESTHER : Zugno_2013_Metab.Brain.Dis_28_501 |
| PubMedSearch : Zugno_2013_Metab.Brain.Dis_28_501 |
| PubMedID: 23775300 |
Zugno AI, Juliao RF, Budni J, Volpato AM, Fraga DB, Pacheco FD, Deroza PF, Luca RD, de Oliveira MB, Heylmann AS, Quevedo J (2013)
Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia
Metabolic Brain Disease
28 :501
Zugno AI, Juliao RF, Budni J, Volpato AM, Fraga DB, Pacheco FD, Deroza PF, Luca RD, de Oliveira MB, Heylmann AS, Quevedo J (2013)
Metabolic Brain Disease
28 :501